Vitreoretinal Surgery via Robotic Microsurgical System with Image Guidance, Force Feedback, Virtual Fixture, and Augmented Reality

通过具有图像引导、力反馈、虚拟夹具和增强现实功能的机器人显微手术系统进行玻璃体视网膜手术

基本信息

  • 批准号:
    10582637
  • 负责人:
  • 金额:
    $ 40.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT The aims of the present proposal are to extend our work with the Intraocular Robotic Interventional and Surgical System (IRISS) and augment it for teleoperated vitreoretinal surgery. Although novel technologies such as intraoperative optical coherence tomography (i-OCT) have been developed, vitreoretinal surgeons still lack critical information during surgery (e.g., the distance between pre-retinal membrane and retina) due to inadequate display and feedback. In addition, physiological capabilities are a limiting factor because the retina is one of the smallest and most delicate tissues of the human body. The rate of surgical failure in complex retinal cases remains high (10–15%) due to the limits of current surgical capabilities, thereby condemning these patients to blindness [1-3]. Our group has developed the IRISS [4-10] through a combination of internal funding and a recent R21 grant (NIH/R21EY024065). This support enabled our group to develop the IRISS platform to perform fully automated cataract surgery on ex-vivo pig eyes. We have also demonstrated the ability of the IRISS to perform safe- motion guidance for lens removal based on per-operative, real-time anatomical detection, and teleoperated capabilities for vitreoretinal maneuvers, including retinal vein cannulation and core vitrectomy [4]. Furthermore, Raven II, an open-source surgical robotics system [11-22], was co-developed by Rosen over the past 16 years for general minimally invasive surgery. In the present study, the surgical cockpit of the Raven II system will serve as the foundation of the user interface for the improved robotic surgical system. The accumulated experience of our group through this previous work will guide the proposed research effort from the stringent clinical requirements to the design, development, and evaluation of the proposed system. The present study is composed of three independent, parallel tracks. First, the mechanical design and assembly of the robotic surgical system will be improved to achieve tool-tip positional precision of 5 µm, approximately ten times more precise than a human surgeon [23]. Second, we will enhance the surgeon's abilities in sensing and interpreting anatomical details during retinal manipulation by applying high-resolution (10 µm), real-time intraoperative i-OCT scans to detect anatomical features critical to specific vitreoretinal procedures. Third, surgical features of interest will be presented to the surgeon via a human–robot surgical cockpit that provides innovative 3D, augmented-reality visualization and auditory and haptic feedback. Each aim will be assessed by a series of evaluation protocols to ensure their success. The safety and efficacy of the system will also be compared with and without the proposed improvements (robotic control, enhanced sensing, and augmented feedback) on a virtual reality simulator in addition to phantom and biological eye models chosen to best assess surgical outcome. It is important to note that while the ultimate goal is the integration of all three aims, their development remains independent and success or failure in one does not affect the outcome of another. We hypothesize that a surgeon–robot surgical system that incorporates enhanced sensing and feedback to enrich the surgeon's perception and interpretation of anatomical details will improve surgical safety and reduce the rate of surgical complications to improve health outcomes and abate the costs associated with surgical complications.
项目摘要/摘要 本提案的目的是通过眼内机器人介入和 手术系统(iRISS)并增加了其进行遗传手术的遗传手术。虽然新颖的技术 已经开发了术中光学相干断层扫描(I-OCT),玻璃体外科医生仍在 由于手术期间缺乏关键信息(例如,视网膜前膜和视网膜之间的距离) 显示和反馈不足。此外,物理能力是一个限制因素,因为视网膜 是人体最小,最细腻的组织之一。复杂的手术衰竭率 由于当前手术能力的限制,视网膜病例仍然很高(10-15%),从而谴责 这些患者失明[1-3]。 我们的小组通过内部资金和最近的R21赠款建立了iriss [4-10] (NIH/R21EY024065)。这种支持使我们的小组能够开发iRiss平台,以执行完全自动化 前病毒眼睛的白内障手术。我们还证明了肌肉执行安全的能力 - 基于每个手术,实时解剖检测和远程处理的镜头去除运动指南 玻璃体测试的能力,包括视网膜静脉插管和核心玻璃体切除术[4]。此外, Raven II是一种开源手术机器人系统[11-22],在过去的16年中由Rosen共同开发 用于一般微创手术。在本研究中,Raven II系统的手术驾驶舱将 作为改进的机器人手术系统的用户界面的基础。积累 我们小组通过这项工作的经验将指导严格的研究工作 对拟议系统的设计,开发和评估的临床要求。 本研究由三个独立的平行轨道组成。首先,机械设计和 机器人手术系统的组装将得到改善,以达到5 µm的工具尖端位置精度, 比人类外科医生要精确的十倍[23]。其次,我们将增强外科医生的 通过应用高分辨率在视网膜操作过程中传感和解释解剖细节的能力 (10 µm),实时术中I-OCT扫描,以检测特定玻璃体测试至关重要的解剖特征 程序。第三,感兴趣的手术特征将通过人类手术出现给外科医生 提供创新的3D,增强真实性可视化和听觉和Hattic反馈的驾驶舱。每个 AIM将通过一系列评估方案进行评估,以确保其成功。的安全性和效率 系统还将与提出的改进进行比较(机器人控制,增强的感应, 除了幻影和生物眼模型外,还针对虚拟现实模拟器增强反馈) 选择最佳评估手术结果。重要的是要注意,虽然最终目标是整合 这三个目标,它们的发展保持独立,成功或失败并不影响 另一个结果。 我们假设一个外科医生 - 肉体手术系统,该系统融合了增强的灵敏度和反馈 丰富了外科医生的看法和解释解剖学细节,将改善手术安全性并减少 改善健康结果并减轻与手术相关的成本的手术并发症率 并发症。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Automated Retinal Vein Cannulation on Silicone Phantoms Using Optical-Coherence-Tomography-Guided Robotic Manipulations.
  • DOI:
    10.1109/tmech.2020.3045875
  • 发表时间:
    2021-10
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Gerber, Matthew J.;Hubschman, Jean-Pierre;Tsao, Tsu-Chin
  • 通讯作者:
    Tsao, Tsu-Chin
A Novel Tissue Identification Framework in Cataract Surgery Using an Integrated Bioimpedance-Based Probe and Machine Learning Algorithms.
使用基于生物阻抗的集成探针和机器学习算法的白内障手术中的新型组织识别框架。
  • DOI:
    10.1109/tbme.2021.3109246
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    AghajaniPedram,Sahba;Ferguson,Peter;Gerber,Matthew;Shin,Changyeob;Hubschman,J-P;Rosen,Jacob
  • 通讯作者:
    Rosen,Jacob
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JACOB ROSEN其他文献

JACOB ROSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JACOB ROSEN', 18)}}的其他基金

Vitreoretinal Surgery via Robotic Microsurgical System with Image Guidance, Force Feedback, Virtual Fixture, and Augmented Reality
通过具有图像引导、力反馈、虚拟夹具和增强现实功能的机器人显微手术系统进行玻璃体视网膜手术
  • 批准号:
    10331767
  • 财政年份:
    2019
  • 资助金额:
    $ 40.18万
  • 项目类别:

相似国自然基金

北极海冰减少对东半球冬季极锋急流减弱趋势影响研究
  • 批准号:
    42375031
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
2015年以来格陵兰海溢流快速减弱的机理与影响
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
醛固酮减弱血管内皮细胞时钟基因Bmal1震荡影响血压晨峰的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
醛固酮减弱血管内皮细胞时钟基因Bmal1震荡影响血压晨峰的机制研究
  • 批准号:
    32260214
  • 批准年份:
    2022
  • 资助金额:
    33.00 万元
  • 项目类别:
    地区科学基金项目
2015年以来格陵兰海溢流快速减弱的机理与影响
  • 批准号:
    42276248
  • 批准年份:
    2022
  • 资助金额:
    56.00 万元
  • 项目类别:
    面上项目

相似海外基金

Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
Creating Pb Risk Mitigation Using Source Apportionment in an EJ Community
在 EJ 社区中使用源解析来降低铅风险
  • 批准号:
    10750503
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
Senescence and Salivary Gland Dysfunction
衰老和唾液腺功能障碍
  • 批准号:
    10892708
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
Addressing Sleep in Adolescents Post-concussion (“ASAP Study”): A Phase 2 Clinical Trial
解决青少年脑震荡后的睡眠问题(“ASAP 研究”):2 期临床试验
  • 批准号:
    10571117
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
A new large pre-clinical model of aging-related heart failure: a platform to develop new therapies for HFpEF
衰老相关心力衰竭的新型大型临床前模型:开发 HFpEF 新疗法的平台
  • 批准号:
    10750836
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了